Navigation Links
MoleSafe USA Opens Second Location in Albuquerque, New Mexico
Date:4/6/2009

Albuquerque the First of Five New Markets Slated to Feature MoleSafe Skin Cancer Detection Facilities in 2009

ALBUQUERQUE, N.M., April 6 /PRNewswire/ -- MoleSafe (www.molesafe.com), a company that offers an advanced skin cancer detection program, announced today it has opened its second U.S. location in Albuquerque, New Mexico. The company opened its first U.S. location in Millburn, New Jersey, in 2008. MoleSafe originated in New Zealand, which is the melanoma capital of the world. The company is scheduled to open in five new markets in the coming year. The Albuquerque location is overseen by Donald Harville, MD, a Board-certified dermatologist.

"As skin cancer continues to become increasingly pervasive in the U.S., taking thousands of lives each year, it is imperative that Americans take precaution," said Dr. Richard Bezozo, president of MoleSafe USA. "MoleSafe provides the most advanced and thorough skin cancer detection programs in the world. We're excited to open our second location in Albuquerque, while expanding our services to reach more cities and help save more lives."

"MoleSafe's advanced program is a proven answer to skin cancer detection, specifically melanoma, which is the deadliest of all skin cancers," said Dr. Donald Harville, manager of the Albuquerque MoleSafe. "When I learned about MoleSafe's technology and system, I was anxious to help bring it to Albuquerque. New Mexico ranks as one of the sunniest states in the country, and thus has one of the highest rates of sun-induced skin cancer."

MoleSafe's four-pronged detection program is utilized by more than 40 melanoma screening centers around the world. To date, MoleSafe has archived more than one million lesions, and close to two and half million lesion images, into its central database. These images have been made available to Memorial Sloan-Kettering Cancer Center and other top institutions in the U.S. for melanoma research and study. Additionally, clinical studies have shown that the number of melanoma cases detected by the MoleMap technology could be up to 15 times greater than those detected via conventional techniques.

The MoleSafe procedure represents a new standard of care and is part of a life-long program for the early detection of melanoma. It has four key elements:

  • Risk assessment: Using its database, MoleSafe has developed a risk assessment model that can help identify patients who may be at higher risk of melanoma;
  • Serial Digital Dermoscopy: Individual moles are imaged microscopically, and tagged to their location on the body for subsequent diagnosis, identification and comparison over time;
  • Diagnosis and Management: The patient's complete skin record, including digital images and clinical information, is sent via a secure tele-dermatology network to MoleSafe's international panel of world-class melanoma dermatologists (dermoscopists) for analysis and reporting. Patients and their designated doctors receive their reports and their digital melanogram. MoleSafe should be considered an integral part of a complete surveillance program for the at-risk melanoma patient.
  • Education and Follow-up: The MoleSafe melanographer, a trained nurse, nurse practitioner or physician assistant educates patients about the risks of sun exposure, and helps generate a continuing partnership between MoleSafe, the patient and his/her doctor.

The MoleSafe Albuquerque location will implement the licensed skin cancer detection program and will be managed by Dr. Donald Harville. Dr. Harville holds his M.D. Degree from the University of Texas Southwestern Medical School and his M.S. Degree in Dermatology from the University of Minnesota.

About MoleSafe

MoleSafe (www.molesafe.com) is a state-of-the-art procedure involving the digital imaging, archiving and diagnosis of moles and other suspicious lesions. The procedure utilizes a combination of high resolution dermoscopy imaging technology that uses high intensity light to penetrate through the surface of the skin to show the structure of moles (and other lesions) and a dermatologist's expert evaluation of the images. In addition to the increased diagnostic accuracy associated with dermoscopy, MoleSafe is able to detect at an earlier stage any new, changing and/or suspicious lesions by monitoring and comparing the images over time. While MoleSafe has the ability to identify all skin cancers, its primary focus is on the early detection of melanoma.


'/>"/>
SOURCE MoleSafe
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MWW Group Retained by MoleSafe
2. Online Celebrity Shoe Charity Auction for Womens Heart Health Opens Bidding
3. An Innovation in Health Care Opens at a CVS/pharmacy Store in the Oklahoma City Region
4. Concentra Opens On-Site Medical Unit at World Trade Center Site
5. Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers
6. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
7. OrthoSynetics(TM) Opens New Data Center, Colocation Facility
8. AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove, Illinois
9. Renovated New Orleans Care Facility Reopens, Reuniting Residents and Staff
10. UCI Medical Affiliates Inc. Opens a New Doctors Care Center in Anderson
11. ARx(TM) Opens New Pharmaceutical Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... San Mateo, CA (PRWEB) , ... February 26, 2017 , ... ... Bay Area cities as diverse as Millbrae, Belmont, and Palo Alto, is proud to ... San Mateo. Many Bay Area consumers look for home care close to home, and ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... in staffing, scheduling, and reporting for healthcare organizations. This comprehensive and customizable ... entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource allocation, collects ...
(Date:2/26/2017)... Florida (PRWEB) , ... February 26, 2017 , ... ... of Parkinson’s disease (PD) in persons with a specific LRRK2 mutation, according to ... Congress. , Previous studies have provided evidence of a link between pesticides and ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... on tooth replacement options at his office, Antoine Dental Center. Currently, patients can ... $18,499. Some restrictions may apply, but patients can learn more about these offers ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic variants ... points to eight genes that may explain why susceptibility to one of the disorders ... a study published today in the journal npj Schizophrenia. , “There is a ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Research and Markets has announced the addition ... Industry Forecast to 2025" report to their offering. ... The Global Wireless Health ... over the next decade to reach approximately $330.5 billion by 2025. ... for all the given segments on global as well as regional ...
(Date:2/24/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... The latest research Dry eye Drugs Price Analysis and Strategies - ... market. The research answers the following questions: ... clinical attributes? How are they positioned in the Global Dry eye market? ...
(Date:2/24/2017)... Juan Monteverde , founder and managing ... boutique securities firm headquartered at the Empire State Building ... that a class action lawsuit has been filed in the ... Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek" or the "Company") on ... 2015 and December 30, 2016, inclusive (the "Class Period").  ...
Breaking Medicine Technology: